Resultados de la búsqueda 221-230 of 1569 for Assay

1. Cirugía - Ensayos clínicos - Mayo Clinic

   This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, test the donors to assure that ...

3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This is a study to generate feasibilty data regarding the collection of health and psychosocial outcomes after acquired spinal cord injury (SCI) ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   We hypothesize that in displaced 3- and 4-part proximal humerus fractures, rTSA will have better pain relief and functional outcomes than nonoperative treatment ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to look at the effects cancer and melanoma have on the immune cells found in lymph nodes. Clinical Outcomes of Patients Treated ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...